About: http://data.cimple.eu/news-article/6cbd8a878c9bd637b0c635207db5360169d76cd78d9a759335420ffc

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/6cbd8a878c9bd637b0c635207db5360169d76cd78d9a759335420ffc Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Patients with abnormally high blood sugar levels are more than twice as likely to die from COVID-19, researchers in China said Saturday. It is the first time scientists have been able to confirm that patients with hyperglycemia, but not diagnosed with diabetes, are at higher risk of death from COVID-19, they wrote in the journal Diabetologia. The researchers examined death rates for 605 COVID-19 patients at two hospitals in Wuhan, China. Having high blood pressure is "independently associated" with increased risk of death and complications from COVID-19, they wrote. The study builds on previous research on diabetic patients. One-in-10 COVID-19 patients with diabetes died in French hospitals, a far higher proportion than for patients without the condition, a May study in the same journal found. Exactly why high blood sugar increases COVID-19 death rates remains clear. The authors of Friday's study suggested that blood clotting, the weakening of blood vessel linings, and cytokine storm syndrome -- an overreaction of the immune system -- could all play a role. The authors of the report urged hospitals to test all COVID-19 patients for glucose levels, as opposed to only those known to have diabetes. The study, which looked at hospital patients admitted in January and February, had some limitations, experts not involved in the research said. "This is a nice report but it is fully in line with expectations," Naveed Sattar, a professor of metabolic medicine at the University of Glasgow who was not one of the study's authors, said. "What the authors cannot confirm is whether differential targeting of blood sugar levels in those admitted leads to differences in outcomes." More research involving randomised controlled trials is needed, Bernard Khoo, a professor of endocrinology at University College London, commented. prk/mh/pvh
schema:headline	High blood sugar elevates COVID mortality risk: Study
schema:mentions	Blood vessel Cytokine release syndrome Endocrinology Hypertension Thrombosis Blood sugar level Clinical trial Medication French language Mortality rate Immune system Diabetes Wuhan Coronavirus disease China Severe acute respiratory syndrome coronavirus 2 Diabetologia University of Glasgow Farooq Sattar Hyperglycemia Differential equation University College London PVH (company)
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-07-10 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	77 (xsd:integer)

Faceted Search & Find service v1.16.123 as of May 22 2025

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3241 as of May 22 2025, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 8 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2026 OpenLink Software